Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2009

01-09-2009 | Review

Adipose Tissue: The New Endocrine Organ? A Review Article

Authors: Susan E. Wozniak, Laura L. Gee, Mitchell S. Wachtel, Eldo E. Frezza

Published in: Digestive Diseases and Sciences | Issue 9/2009

Login to get access

Abstract

Fat is either white or brown, the latter being found principally in neonates. White fat, which comprises adipocytes, pre-adipocytes, macrophages, endothelial cells, fibroblasts, and leukocytes, actively participates in hormonal and inflammatory systems. Adipokines include hormones such as leptin, adiponectin, visfatin, apelin, vaspin, hepcidine, chemerin, omentin, and inflammatory cytokines, including tumor necrosis factor alpha (TNF), monocyte chemoattractant protein-1 (MCP-1), and plasminogen activator protein (PAI). Multiple roles in metabolic and inflammatory responses have been assigned to adipokines; this review describes the molecular actions and clinical significance of the more important adipokines. The array of adipokines evidences diverse roles for adipose tissue, which looms large in the mediators of inflammation and metabolism. For this reason, treating obesity is more than a reduction of excess fat; it is also the treatment of obesity’s comorbidities, many of which will some day be treated by drugs that counteract derangements induced by adipokine excesses.
Literature
1.
go back to reference Von Gierke E. Ueber Fett Metabolism. Der Deutsch Ges Path. 1906;10:182–185. Von Gierke E. Ueber Fett Metabolism. Der Deutsch Ges Path. 1906;10:182–185.
3.
go back to reference Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol. 2000;68:437–446.PubMed Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol. 2000;68:437–446.PubMed
4.
go back to reference Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature. 1998;394:897–901. doi:10.1038/29795.PubMedCrossRef Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature. 1998;394:897–901. doi:10.​1038/​29795.PubMedCrossRef
5.
7.
go back to reference Blum WF, Englaro P, Hatsch S, et al. Plasma leptin levels in healthy children and adolescents: dependence on BMI, body fat mass, gender, pubertal stage, and testosterone. Clin Endocrinol Metab. 1997;82:2904–2910. doi:10.1210/jc.82.9.2904.CrossRef Blum WF, Englaro P, Hatsch S, et al. Plasma leptin levels in healthy children and adolescents: dependence on BMI, body fat mass, gender, pubertal stage, and testosterone. Clin Endocrinol Metab. 1997;82:2904–2910. doi:10.​1210/​jc.​82.​9.​2904.CrossRef
9.
go back to reference Ashwin PJ, Dilipbhai PJ. Leptin and the cardiovascular system: a review. Recent Pat Cardiovasc Drug Discov. 2007;2:100–109.PubMedCrossRef Ashwin PJ, Dilipbhai PJ. Leptin and the cardiovascular system: a review. Recent Pat Cardiovasc Drug Discov. 2007;2:100–109.PubMedCrossRef
12.
go back to reference Huo L, Müzberg H, Nillni EA, Bjorbaek C. Role of signal transducer and activator of transcription 3 in regulation of hypothalamic trh gene expression by leptin. Endocrinology. 2004;145:2516–2523. doi:10.1210/en.2003-1242.PubMedCrossRef Huo L, Müzberg H, Nillni EA, Bjorbaek C. Role of signal transducer and activator of transcription 3 in regulation of hypothalamic trh gene expression by leptin. Endocrinology. 2004;145:2516–2523. doi:10.​1210/​en.​2003-1242.PubMedCrossRef
16.
go back to reference Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002;110:1093–1103.PubMed Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002;110:1093–1103.PubMed
19.
go back to reference Gesta S, Tseng YH, Kahn CR. Developmental origin of fat: tracking obesity to its source. Cell. 2007;131(2):242–256. 19.PubMedCrossRef Gesta S, Tseng YH, Kahn CR. Developmental origin of fat: tracking obesity to its source. Cell. 2007;131(2):242–256. 19.PubMedCrossRef
23.
go back to reference Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun. 2005;334:1092–1101. doi:10.1016/j.bbrc.2005.06.202.PubMedCrossRef Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun. 2005;334:1092–1101. doi:10.​1016/​j.​bbrc.​2005.​06.​202.PubMedCrossRef
24.
go back to reference Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005;174:5789–5795.PubMed Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005;174:5789–5795.PubMed
29.
go back to reference Axelsson J, Bergsten A, Qureshi AR, et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int. 2006;69:596–604. doi:10.1038/sj.ki.5000089.PubMedCrossRef Axelsson J, Bergsten A, Qureshi AR, et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int. 2006;69:596–604. doi:10.​1038/​sj.​ki.​5000089.PubMedCrossRef
31.
go back to reference Mao X, Kikani CK, Riojas RA, et al. APPL1 binds to adiponectin receptors and mediates adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol. 2006;8:516–523. doi:10.1038/ncb1404.PubMedCrossRef Mao X, Kikani CK, Riojas RA, et al. APPL1 binds to adiponectin receptors and mediates adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol. 2006;8:516–523. doi:10.​1038/​ncb1404.PubMedCrossRef
32.
33.
34.
37.
go back to reference Ouedraogo R, Wu X, Xu SQ, et al. Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes. 2006;55(6):1840–1846. doi:10.2337/db05-1174.PubMedCrossRef Ouedraogo R, Wu X, Xu SQ, et al. Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes. 2006;55(6):1840–1846. doi:10.​2337/​db05-1174.PubMedCrossRef
38.
go back to reference Matsuo Y, Imanishi T, Kuroi A, et al. Effects of plasma adiponectin levels on the number and function of endothelial progenitor cells in patients with coronary artery disease. Circ J. 2007;71:1376–1382. doi:10.1253/circj.71.1376.PubMedCrossRef Matsuo Y, Imanishi T, Kuroi A, et al. Effects of plasma adiponectin levels on the number and function of endothelial progenitor cells in patients with coronary artery disease. Circ J. 2007;71:1376–1382. doi:10.​1253/​circj.​71.​1376.PubMedCrossRef
39.
go back to reference Ouchi N, Kobayashi H, Kihara S, et al. Adiponectin stimulates angiogenesis by promothing cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem. 2003;279:1304–1309. doi:10.1074/jbc.M310389200.PubMedCrossRef Ouchi N, Kobayashi H, Kihara S, et al. Adiponectin stimulates angiogenesis by promothing cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem. 2003;279:1304–1309. doi:10.​1074/​jbc.​M310389200.PubMedCrossRef
41.
43.
45.
go back to reference Kiris I, Tekin I, Yesildag A, et al. Inverse relationship between adiponectin levels and subclinical carotid athersclerosis in patients undergoing coronary artery bypass grafting. Int Heart J. 2006;47:855–866. doi:10.1536/ihj.47.855.PubMedCrossRef Kiris I, Tekin I, Yesildag A, et al. Inverse relationship between adiponectin levels and subclinical carotid athersclerosis in patients undergoing coronary artery bypass grafting. Int Heart J. 2006;47:855–866. doi:10.​1536/​ihj.​47.​855.PubMedCrossRef
48.
53.
go back to reference Higuchi K, Masaki T, Goth K, et al. Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice. Endocrinology. 2007;148:2690–2697. doi:10.1210/en.2006-1270.PubMedCrossRef Higuchi K, Masaki T, Goth K, et al. Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice. Endocrinology. 2007;148:2690–2697. doi:10.​1210/​en.​2006-1270.PubMedCrossRef
55.
go back to reference Jia S, Li Y, Parodo J, et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest. 2004;113:1318–1327.PubMed Jia S, Li Y, Parodo J, et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest. 2004;113:1318–1327.PubMed
61.
63.
go back to reference White RT, Damm D, Hancock N, et al. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J Biol Chem. 1992;267:9210–9213.PubMed White RT, Damm D, Hancock N, et al. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J Biol Chem. 1992;267:9210–9213.PubMed
65.
go back to reference Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and Type II diabetes. Nature. 2005;436:356–362.PubMedCrossRef Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and Type II diabetes. Nature. 2005;436:356–362.PubMedCrossRef
66.
go back to reference Mandard S, Zandbergen F, van Straten E, et al. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasm lipid levels and adiposity. J Biol Chem. 2006;281:934–944. doi:10.1074/jbc.M506519200.PubMedCrossRef Mandard S, Zandbergen F, van Straten E, et al. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasm lipid levels and adiposity. J Biol Chem. 2006;281:934–944. doi:10.​1074/​jbc.​M506519200.PubMedCrossRef
67.
go back to reference Mandard S, Zandbergen F, Tan NS, et al. The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J Biol Chem. 2004;279:34411–34420. doi:10.1074/jbc.M403058200.PubMedCrossRef Mandard S, Zandbergen F, Tan NS, et al. The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J Biol Chem. 2004;279:34411–34420. doi:10.​1074/​jbc.​M403058200.PubMedCrossRef
68.
go back to reference Wang Y, Lam KS, Lam JB, et al. Overexpression of Angiopoietin-like protein 4 alters mitochondria activities and modulates methionine metabolic cycle in the liver tissues of db/db diabetic mice. Mol Endocrinol. 2007;21:972–986. doi:10.1210/me.2006-0249.PubMedCrossRef Wang Y, Lam KS, Lam JB, et al. Overexpression of Angiopoietin-like protein 4 alters mitochondria activities and modulates methionine metabolic cycle in the liver tissues of db/db diabetic mice. Mol Endocrinol. 2007;21:972–986. doi:10.​1210/​me.​2006-0249.PubMedCrossRef
71.
go back to reference Oppenheim JJ, Feldmann M. Introduction to the role of cytokines in innate host defense and adaptative immunity. Elsevier; 2001:3–20. Oppenheim JJ, Feldmann M. Introduction to the role of cytokines in innate host defense and adaptative immunity. Elsevier; 2001:3–20.
72.
go back to reference Wang B, Trayhurn P. Acute and prolonged effects of TNF-alpha on the expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture. Pflugers Arch. 2006;452:418–427. doi:10.1007/s00424-006-0055-8.PubMedCrossRef Wang B, Trayhurn P. Acute and prolonged effects of TNF-alpha on the expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture. Pflugers Arch. 2006;452:418–427. doi:10.​1007/​s00424-006-0055-8.PubMedCrossRef
76.
go back to reference Maruyoshi H, Kojima S, Funahashi T, et al. Adiponectin is inversely related to plasminogen activator inhibitor type 1 in patients with stable exertional angina. Thromb Haemost. 2004;91:1026–1030.PubMed Maruyoshi H, Kojima S, Funahashi T, et al. Adiponectin is inversely related to plasminogen activator inhibitor type 1 in patients with stable exertional angina. Thromb Haemost. 2004;91:1026–1030.PubMed
78.
go back to reference Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG. Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes. 2004;28:S58–S65. doi:10.1038/sj.ijo.0802858.CrossRef Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG. Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes. 2004;28:S58–S65. doi:10.​1038/​sj.​ijo.​0802858.CrossRef
83.
go back to reference Chabowski A, Zmijewska M, Gorski J, Bonen A, Kamiński K, Winnicka MM. Effect of IL-6 deficiency on myocardial expression of fatty acid transporters and intracellular lipid deposits. J Physiol Pharmacol. 2007;58:73–82.PubMed Chabowski A, Zmijewska M, Gorski J, Bonen A, Kamiński K, Winnicka MM. Effect of IL-6 deficiency on myocardial expression of fatty acid transporters and intracellular lipid deposits. J Physiol Pharmacol. 2007;58:73–82.PubMed
86.
go back to reference Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6:772–783.PubMedCrossRef Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6:772–783.PubMedCrossRef
87.
go back to reference Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M. Recent advances in the relationship between obesity, inflammation and insulin resistance. Eur Cytokine Netw. 2006;17:4–12.PubMed Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M. Recent advances in the relationship between obesity, inflammation and insulin resistance. Eur Cytokine Netw. 2006;17:4–12.PubMed
Metadata
Title
Adipose Tissue: The New Endocrine Organ? A Review Article
Authors
Susan E. Wozniak
Laura L. Gee
Mitchell S. Wachtel
Eldo E. Frezza
Publication date
01-09-2009
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2009
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0585-3

Other articles of this Issue 9/2009

Digestive Diseases and Sciences 9/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.